Navigation Links
BiOptix Announces Fall 2012 Tradeshow and Symposia Schedule
Date:8/22/2012

BOULDER, Colo., Aug. 22, 2012 /PRNewswire/ -- BiOptix today officially announced its fall 2012 Tradeshow and Symposia schedule.  These events will highlight the BiOptix Enhanced Surface Plasmon Resonance (ESPR) technology and the forthcoming BiOptix 404pi, a novel and game-changing label-free SPR instrument for kinetic detection. BiOptix Events for fall 2012 include:

  • 34th Semiannual Biotechnology Symposia, University of California, San Diego:  August 23rd
  • HUPO – 11th Annual World Congress:  September 9 – 13th
  • BioWest 2012:   September 11th
  • MipTec:  September 25 – 27th
  • NIH Research Festival:  October 11 – 12th
  • AAPS–American Association of Pharmaceutical Scientists:  October 14 – 17th
  • 22nd Annual Bristol-Myers Squibb R&D Symposium:  October 29 – 30th
  • Label-Free Technologies–Advances and Applications:   November 1 – 3rd
  • 4th Annual PEGS-Europe Conference:  November 6 – 8th
  • Antibody Engineering–23rd Annual International Conference:   December 2 – 6th

(Logo: http://photos.prnewswire.com/prnh/20120822/LA61037LOGO)

"BiOptix is excited to be represented at and participate in some of the most prestigious scientific events in Europe and North America for the balance of 2012," noted Ken Wilczek, Vice President of Sales and Marketing for BiOptix. "2012 has been groundbreaking for BiOptix, as we have met with and presented our unique SPR technology to over 3,000 scientific researchers so far. We are enthusiastic to present the BiOptix value proposition to additional scientific researchers in the months ahead."

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix

BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com


'/>"/>
SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Interventional Spine Announces its 75th Patient Treated with the PerX360 Percutaneous Spinal Fusion Technology
2. Precision Automation Expert DWFritz Automation Announces Website Launch www.DWFritz.com
3. CPhI South America Expands Offering for 2013, Announces Co-Location with Food Ingredients South America
4. EFJohnson Announces Impact Partner Dealer Program
5. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
6. Kallo Announces Purchase Order For Its Specialist EMR - EMCURx
7. CryoLife Announces Initiation of Quarterly Cash Dividend
8. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
9. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
10. Angeion Announces Name Change and New Trading Symbol Effective Tuesday, August 21, 2012
11. VWR Funding, Inc. Announces Proposed Offering Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... PARIS , le 27 Avril 2016 /PRNewswire/ ... chiffre d,affaires a progressé de +5% sur le ... ventes récurrentes de consommables  Croissance de ... Mauna Kea Technologies (Euronext : ... multidisciplinaire d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre ...
(Date:4/27/2016)... 2016   Zillion Group today announced ... platform, which specializes in live video consultation. Turning ... products, Zillion enables companies to realize the true ... take control of their health. ... including one-to-one, group and webcast scheduled or on-demand ...
(Date:4/27/2016)... , April 27, 2016 ... of the  "Global Anesthesia Disposables Market 2016-2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ,The global anesthesia disposables ... CAGR of 4.03% during the period 2016-2020.  ... major threat to patients, safety. Organizations like ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... 29, 2016 , ... Sublime Beauty® is offering a special deal on its webstore. , Buy ... discount is applied to the product with lesser value. In addition, a free bonus ... or more in products. , "So many women (men, too) love our products and get ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... the world stage this week. A group of researchers and leaders from Sanford ... Progress of Regenerative Medicine and Its Cultural Impact ” and receive the 2016 ...
(Date:4/28/2016)... ... April 28, 2016 , ... La Sirena Foods provides premium ... Central America and is looking to grow their market share in the USA. , ... brand as La Sirena Foods and indirectly with Otis McAllister , ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... availability of a new CDISC standard, Clinical Trial Registry (CTR) XML. Clinical ... innovative standard will make it possible to build applications that generate submissions ...
Breaking Medicine News(10 mins):